EVALUATION OF LIPID PROFILE AND LIVER FUNCTION PARAMETERS IN OBESE AND NON-OBESE HYPERTENSIVE INDIVIDUALS ATTENDED TERTIARY CARE TEACHING HOSPITAL

PRASAD RAO M.; SPURGEON RAJ JALEM; BARLA BSV SATYA KUMAR; SMRUTI SANGAM

doi:10.22159/ijcpr.2023v15i3.3002

Authors

PRASAD RAO M. Department of General Surgery, NRI Institute of Medical Sciences and Anil Neerukonda Hospital, Sangivalasa, Visakhapatnam, India
SPURGEON RAJ JALEM Intensivist, Critical Care and Emergency Medicine, Bliss Hospital, Hyderabad, India
BARLA BSV SATYA KUMAR Department of General Surgery, NRI Institute of Medical Sciences and Anil Neerukonda Hospital, Sangivalasa, Visakhapatnam, India
SMRUTI SANGAM Department of General Medicine, NRI Institute of Medical Sciences and Anil Neerukonda Hospital, Sangivalasa, Visakhapatnam, India

DOI:

https://doi.org/10.22159/ijcpr.2023v15i3.3002

Keywords:

Dyslipidemia, Lipid profile, Hypertension, Obese, Non-obese

Abstract

Objective: In this study, lipid profile parameters and liver function parameters were measured and correlated in hypertensive obese and non-obese patients who were attended a tertiary care teaching hospital.

Methods: This study is a retrospective observational, cross-sectional study over the course of a year in a tertiary care hospital. All adult patients with hypertension, both obese and non-obese, are included in the study population. The study involved 150 participants in total, including obese and non-obese people (71 men and 79 women). Standard techniques were used to assess the serum levels of TG, TC, LDL, HDL, and liver enzymes such SGOT, SGPT, bilirubin, and ALP. Moreover, BMI was calculated for both study groups. The association between elevated lipid profile markers and liver enzyme abnormalities was assessed by correlation analysis.

Results: Out of 150 samples size comprises 75 obese and 75 non-obese individuals, 71 males and 79 females were reported in the current study. Our study gives very good association between lipid profiles to almost all LFT and the highest is shown between HDL, LDL and VLDL to all LFT. There was a high significant difference was noticed between the obese and non-obese individuals in relation to bilirubin (D) concentration, SGOT and SGPT between the two groups P<0.0001. The levels of albumin were lowered and the significant variations were noticed between the two groups. The mean values of cholesterol, LDL and triglycerides were very high in obese individuals than non-obese individuals and the HDL was lower in obese individuals.

Conclusion: The study found that liver function variables and abnormal lipid profiles were highly prevalent in obese hypertension patients. In participants with dyslipidemia, increased liver enzymes were seen more frequently.

Downloads

Download data is not yet available.

References

Badiuzzamam M, Mohammed F, Chowdhury F, Bari M, Alam M, Ahasan H. Prevalence of modiafiable risk factors among stroke patients in a Tertiary Care Hospital in Dhaka. J Med. 2012;10:18-21.

Kannel WB, Castelli WP, Gordon T, Mcnamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The framingham study. Ann Intern Med. 1971;74(1):1-12. doi: 10.7326/0003-4819-74-1-1, PMID 5539274.

Ahirwar R, Mondal PR. Prevalence of obesity in India: a systematic review. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):318-21. doi: 10.1016/j.dsx.2018.08.032. PMID 30641719.

Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689-700. doi: 10.1038/s41569-021-00541-4, PMID 33833450.

Gebrie A, Gnanasekaran N, Menon M, Sisay M, Zegeye A. Evaluation of lipid profiles and hematological parameters in hypertensive patients: laboratory-based cross-sectional study. SAGE Open Med. 2018 Feb 12;6:2050312118756663. doi: 10.1177/2050312118756663, PMID 29468066.

Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR. The metabolic syndrome. Endocr Rev. 2008 Dec;29(7):777-822. doi: 10.1210/er.2008-0024, PMID 18971485.

Laaksonen DE, Niskanen L, Nyyssonen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008 Oct;29(20):2561-8. doi: 10.1093/eurheartj/ehn061, PMID 18308688.

Paynter NP, Sesso HD, Conen D, Otvos JD, Mora S. Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin Chem. 2011 Aug;57(8):1178-87. doi: 10.1373/clinchem.2011.167544, PMID 21700954.

Shabana, Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis. 2020;19(1):73. doi: 10.1186/s12944-020-01248-0, PMID 32290855.

Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded ”double-trouble” lipid profile in overweight/obese. Adv Ther. 2019;36(6):1426-37. doi: 10.1007/s12325-019-00941-6, PMID 30953331.

Reza CM, Kabir ASMA, Biswas T, Choudhury KN, Rahman MZ, Hussain DA. Status of lipid profile among the hypertensive patients in Bangladesh. Univ Heart J. 2014;9(1):13-7. doi: 10.3329/uhj.v9i1.19505.

Ghooshchi G, Masoomian M, Yazdi MS. Evaluation of the lipid profile of hypertensive patients compared to non-hypertensive individuals. Patient Saf Qual Improv J. 2014;2:120-3.

Prabhanjan K, Moges B, Yohannes A. A study of lipid profiles in hypertensive patients visiting Dilla University Referral Hospital. Int J Sci Res. 2014;3:2336-8.

Aakash Srivastava, BK Binawara. Comparative study on lipid profile of hypertensive patients and non-hypertensive individuals in bikaner, Rajasthan, India. PBJ 2016;4(4):62-6. doi: 10.20510/ukjpb/4/i4/112412.

Nayak P, Panda S, Thatoi PK, Rattan R, Mohapatra S, Mishra PK. Evaluation of lipid profile and apolipoproteins in essential hypertensive patients. J Clin Diagn Res. 2016;10(10):BC01-4. doi: 10.7860/JCDR/2016/20985.8626, PMID 27891330.

Bhowmik B, Siddiquee T, Mujumder A, Afsana F, Ahmed T, Mdala IA. Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population. Int J Environ Res Public Health. 2018;15(9):1944. doi: 10.3390/ijerph15091944, PMID 30200612.

Choudhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS. Serum lipid profile and its association with hypertension in Bangladesh. Vasc Health Risk Manag. 2014;10:327-32. doi: 10.2147/VHRM.S61019, PMID 25061312.

Atiba AS, Oparinde DP, Adeyemi O, Jimoh AK, Adepeju AA. Liver enzymes and lipid profile among type 2 diabetic patients in Osogbo, By. Greener J Sci. 2013;3:174-8.

Kim HR, Han MA. Association between serum liver enzymes and metabolic syndrome in Korean adults. Int J Environ Res Public Health. 2018;15(8):1658. doi: 10.3390/ijerph15081658, PMID 30081587.

Hanley AJG, Williams K, Festa A, Wagenknecht LE, D’Agostino RB, Kempf J. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004;53(10):2623-32. doi: 10.2337/ diabetes.53.10.2623, PMID 15448093.